Literature DB >> 15694274

Analysis of the trinucleotide CAG repeat from the DNA polymerase gamma gene (POLG) in patients with Parkinson's disease.

Jan-Willem Taanman1, Anthony H V Schapira.   

Abstract

The human gene for the catalytic subunit of the mitochondrial DNA (mtDNA) polymerase (POLG) contains a trinucleotide CAG repeat encoding a polyglutamine tract near the amino-terminus of the protein. Expansions of similar polyglutamine-encoding CAG microsatellite repeats in other genes are known to cause neurodegenerative disorders. As mitochondrial dysfunction has been implicated in the aetiology of Parkinson's disease, we determined the POLG CAG repeat length in DNA samples extracted from 22 idiopathic Parkinson's disease patients and 31 control subjects. The distribution of the POLG CAG repeat length in the control samples matched the distribution reported for control samples by others. Comparison between the CAG repeat length distribution of control and Parkinson's disease samples revealed no evidence of either germ line or somatic POLG CAG repeat instability in Parkinson's disease patients. Our results rule out POLG CAG repeat instability as a common pathogenic mechanism in idiopathic Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15694274     DOI: 10.1016/j.neulet.2004.11.023

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  14 in total

1.  Huntington's disease and mitochondrial DNA deletions: event or regular mechanism for mutant huntingtin protein and CAG repeats expansion?!

Authors:  Mohammad Mehdi Banoei; Massoud Houshmand; Mehdi Shafa Shariat Panahi; Parvin Shariati; Maryam Rostami; Masoumeh Dehghan Manshadi; Tayebeh Majidizadeh
Journal:  Cell Mol Neurobiol       Date:  2007-10-20       Impact factor: 5.046

Review 2.  Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis.

Authors:  Rebecca Banerjee; Anatoly A Starkov; M Flint Beal; Bobby Thomas
Journal:  Biochim Biophys Acta       Date:  2008-11-14

3.  POLG1 polyglutamine tract variants associated with Parkinson's disease.

Authors:  Johanna Eerola; Petri T Luoma; Terhi Peuralinna; Sonja Scholz; Coro Paisan-Ruiz; Anu Suomalainen; Andrew B Singleton; Pentti J Tienari
Journal:  Neurosci Lett       Date:  2010-04-24       Impact factor: 3.046

4.  Mitochondrial contribution to Parkinson's disease pathogenesis.

Authors:  Anthony H V Schapira; Matthew Gegg
Journal:  Parkinsons Dis       Date:  2011-04-28

Review 5.  Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism.

Authors:  David N Hauser; Teresa G Hastings
Journal:  Neurobiol Dis       Date:  2012-10-12       Impact factor: 5.996

6.  Parkinson's disease: genetics and beyond.

Authors:  N N Inamdar; D K Arulmozhi; A Tandon; S L Bodhankar
Journal:  Curr Neuropharmacol       Date:  2007       Impact factor: 7.363

Review 7.  Role of the mitochondrial DNA replication machinery in mitochondrial DNA mutagenesis, aging and age-related diseases.

Authors:  Karen L DeBalsi; Kirsten E Hoff; William C Copeland
Journal:  Ageing Res Rev       Date:  2016-04-30       Impact factor: 10.895

Review 8.  Molecular and clinical prodrome of Parkinson disease: implications for treatment.

Authors:  Anthony H V Schapira; Eduardo Tolosa
Journal:  Nat Rev Neurol       Date:  2010-05-18       Impact factor: 42.937

9.  Multiple oxidative phosphorylation deficiencies in severe childhood multi-system disorders due to polymerase gamma (POLG1) mutations.

Authors:  Maaike C de Vries; Richard J Rodenburg; Eva Morava; Edwin P M van Kaauwen; Henk ter Laak; Reinier A Mullaart; Irina N Snoeck; Peter M van Hasselt; Peter Harding; Lambert P W van den Heuvel; Jan A M Smeitink
Journal:  Eur J Pediatr       Date:  2006-09-07       Impact factor: 3.860

Review 10.  Mitochondrial dysfunction in neurodegenerative diseases.

Authors:  Anthony H V Schapira
Journal:  Neurochem Res       Date:  2008-11-08       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.